These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26724262)

  • 1. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study.
    Patel SV; Nimavat KB; Alpesh PB; Shukla LK; Shringarpure KS; Mehta KG; Joshi CC
    J Infect Public Health; 2016; 9(4):478-84. PubMed ID: 26724262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
    Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
    Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India.
    Saharia GK; Ruram AA; Lyngwa J
    Indian J Tuberc; 2015 Jul; 62(3):166-70. PubMed ID: 26600329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
    Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
    Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions.
    Janmeja AK; Aggarwal D; Dhillon R
    Indian J Tuberc; 2018 Apr; 65(2):135-139. PubMed ID: 29579427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.
    Karagöz T; Yazicioğlu Moçin O; Pazarli P; Senol T; Yetiş Duman D; Duman G; Saltürk C; Unal O; Halezeroğlu S
    Tuberk Toraks; 2009; 57(4):383-92. PubMed ID: 20037853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome of multidrug-resistant Mycobacterium tuberculosis in Nepal.
    Kakchapati S; Gyawali BN; Jha RK; Choonpradub C
    Asia Pac J Public Health; 2012 Jul; 24(4):631-40. PubMed ID: 22652251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.